AU1392800A - Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant - Google Patents

Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant

Info

Publication number
AU1392800A
AU1392800A AU13928/00A AU1392800A AU1392800A AU 1392800 A AU1392800 A AU 1392800A AU 13928/00 A AU13928/00 A AU 13928/00A AU 1392800 A AU1392800 A AU 1392800A AU 1392800 A AU1392800 A AU 1392800A
Authority
AU
Australia
Prior art keywords
immunosuppressant
angiotensin
combination
receptor antagonist
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13928/00A
Other languages
English (en)
Inventor
Joelle Sissmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU1392800A publication Critical patent/AU1392800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13928/00A 1998-12-18 1999-12-01 Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant Abandoned AU1392800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9816085 1998-12-18
FR9816085A FR2787330A1 (fr) 1998-12-18 1998-12-18 Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe
PCT/FR1999/002972 WO2000037075A1 (fr) 1998-12-18 1999-12-01 Combination d'un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur

Publications (1)

Publication Number Publication Date
AU1392800A true AU1392800A (en) 2000-07-12

Family

ID=9534202

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13928/00A Abandoned AU1392800A (en) 1998-12-18 1999-12-01 Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant

Country Status (3)

Country Link
AU (1) AU1392800A (fr)
FR (1) FR2787330A1 (fr)
WO (1) WO2000037075A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0102252B1 (pt) 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
DE10123929A1 (de) * 2001-05-11 2002-11-21 Celltrend Gmbh Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit
US8980870B2 (en) 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10244681A1 (de) * 2002-09-24 2004-04-08 Boehringer Ingelheim International Gmbh Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung
PL1750862T3 (pl) 2004-06-04 2011-06-30 Teva Pharma Kompozycja farmaceutyczna zawierająca irbesartan
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1884776A1 (fr) 2006-08-04 2008-02-06 Celltrend GmbH Procede diagnostique pour une maladie basee sur la presence d'anticorps d'endotheline
PL1884775T3 (pl) 2006-08-04 2010-06-30 Celltrend Gmbh Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1

Also Published As

Publication number Publication date
FR2787330A1 (fr) 2000-06-23
WO2000037075A1 (fr) 2000-06-29

Similar Documents

Publication Publication Date Title
AU2407997A (en) Combined use of gnrh agonist and antagonist
AU7079498A (en) Neuropeptide y receptor antagonist
AU3860800A (en) Authentication system and methodology
AU3034300A (en) Substituted benzimidazoles and their use as parp inhibitors
EP1085887A4 (fr) Nouveaux modulateurs des r cepteurs de l'angiotensine et leurs utilisations
AU7315800A (en) Mch antagonists
EP1093803A3 (fr) Composition cosmétique contenant un antagoniste des récepteurs du neuropeptide Y
AU1553199A (en) Antagonists of g-protein-coupled receptor
AU1920301A (en) Receptor activator of nf-kappa b
AU1926000A (en) Pth1r and pth3r receptors
AUPP278498A0 (en) Peripheral benzodiazepine receptor binding agents
PL352056A1 (en) Antagonists of bradykinin receptor
AU5901900A (en) Indole and indazole urea-peptoids as thrombin receptor antagonists
AU1392800A (en) Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant
AU3075200A (en) Telephone and telephone system
AU5522399A (en) Pharmaceutical composition containing an angiotensin ii AT1 receptor antagonist and an antiplatelet agent
GB2337701A8 (en) Treatment of ischemia with an angiotensin II antagonist
AU6317996A (en) Peptide derivatives and angiotensin iv receptor agonist
AU5861900A (en) Receptor agonists and antagonists
AU6503900A (en) Chemokine receptor antagonists and methods of use therefor
AU2662799A (en) Modified pharmacologically active agents and improved therapeutic methods employing same
AU6389900A (en) Chemokine receptor antagonists and methods of use therefor
GB9820014D0 (en) Receptor antagonists and uses thereof
AU2429100A (en) Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase